Skip to main content

Table 2 Comparison of blood pressure and blood lipid levels before and after treatment between the two groups (\(\stackrel{-}{x}\) ± SD)

From: Effect and mechanism of HMG-CoA reductase inhibitor on the improvement of elderly essential hypertension-induced vascular endothelial function impairment based on the JAK/STAT pathway

Indicator

 

Control group (n = 43)

Observation group (n = 43)

SBP (mmHg)

Before treatment

156.23 ± 7.61

155.40 ± 6.87

After treatment

141.74 ± 6.62*

130.17 ± 5.69*#

DBP (mmHg)

Before treatment

98.18 ± 6.35

96.76 ± 6.30

After treatment

90.65 ± 5.23*

75.36 ± 5.52*#

TC (mmol/L)

Before treatment

6.67 ± 0.91

6.72 ± 0.85

After treatment

5.14 ± 0.68*

4.06 ± 0.65*#

TG (mmol/L)

Before treatment

2.39 ± 0.34

2.45 ± 0.28

After treatment

1.88 ± 0.25*

1.42 ± 0.19*#

LDL-C (mmol/L)

Before treatment

3.84 ± 0.65

3.90 ± 0.81

After treatment

3.06 ± 0.72*

2.58 ± 0.55*#

HDL-C (mmol/L)

Before treatment

1.03 ± 0.41

1.02 ± 0.34

After treatment

1.24 ± 0.25*

1.42 ± 0.31*#

  1. Note: * p < 0.05 vs. Before treatment; # p < 0.05 vs. Control group
Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us